PCT LTD Provides Update to Public, Distributors and Subregistrants Regarding Use of Products

PCT LTD (OTC Pink: PCTL) is providing this release to address specific questions which have been raised regarding the use and distribution of their products by unrelated or 3rd party entities.

PCT LTD has been made aware of, and continues to investigate, the use of PCT LTD products by other companies. PCT LTD is aware of certain companies making claims which include, but are not limited to:

• Claims regarding PCT LTD’s relationship with an entity where no relationship exists
• Claims regarding PCT LTD’s products, including efficacy and applications, which have not been sanctioned by PCT LTD or are not within the guidelines of PCT LTD’s US EPA registration.
• Usage of PCT LTD’s products which have not been vetted or sanctioned by PCT LTD or are not within the guidelines of the company’s US EPA registration.
• Expressed inferences and/or references to the US EPA’s List N without the required US EPA emerging pathogen verbiage and directions.

The company thoroughly vets all distributors and subregistrants prior to entering into a legally binding agreement. Such agreements include terms regarding usage and representation of PCT LTD’s products and claims, terms, and language which may be used (or not used) while representing PCT LTD’s US EPA Registration 92108-1 (Alternate brand name: Hydrolyte®) registration.

“Because our vetting process is so rigorous, anyone who is legitimately using our supplemental US EPA registration deserves a firm stance on this issue from us,” explains PCT LTD CEO Gary Grieco. “Let it be known, and you can quote me on this, that we will rigorously defend our brand, products, and our highly valuable and coveted US EPA product registration from misuse or misrepresentation from outside companies which have no business making such claims, including legal action if necessary.”

The Company is and will actively continue to take action through appropriate legal and regulatory channels to address any misuse or misrepresentation of its products.

Additional News and Corporate Updates:

PCTL would like to warn its stockholders and potential investors that material corporate information regarding sales, areas of business and other corporate updates will only be made through press releases or filings with the SEC. PCTL does not utilize social media, chatrooms or other online sources to disclose material information. The public should only rely on official press releases and corporate filings for accurate and up to date information regarding PCTL.

About PCT LTD:

PCT LTD ("PCTL") focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting, cleaning and tracking technologies. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC, "PCTL" aspires to and is actively engaged in preparations for up-listing its common stock to a national securities exchange. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K.

Forward-Looking Statements:

This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements."

Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: the ability of PCTL to monitor and defend against misuses of its US EPA registered product; PCTL’s most recently added distributors to gain and maintain certain saturation levels within their regions and/or markets; PCTL’s continued installation of equipment; subsequent installations of PCT’s Annihilyzer Infection Control Systems; the availability of audit, accounting and legal professionals during the pandemic and the impact of COVID-19 on the timeframe of filing PCTL’s 2020 Q1 10-Q; PCTL's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCTL to execute its business plan; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCTL makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the SEC. PCTL undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200717005334/en/